Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and projections of the Global Economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465–72.

Article  PubMed  PubMed Central  Google Scholar 

Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, et al. Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO Open. 2018;3(2):e000285.

Article  PubMed  PubMed Central  Google Scholar 

National Cancer Institute Cancer Statistics. 2020 [ https://www.cancer.gov/about-cancer/understanding/statistics.

Institute of Medicine Cancer Care for the Whole Patient. In: Adler NE, Page AEK, editors. Meeting Psychosocial Health needs. Washington, DC: The National Academies; 2008. p. 454.

Google Scholar 

Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2–4.

CAS  PubMed  Google Scholar 

Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469–75.

Article  PubMed  Google Scholar 

McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, et al. Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin. 2011;61(1):50–62.

Article  PubMed  PubMed Central  Google Scholar 

Lorig KR, Sobel DS, Stewart AL, Brown BW Jr., Bandura A, Ritter P, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999;37(1):5–14.

Article  CAS  PubMed  Google Scholar 

Skolasky RL, Mackenzie EJ, Wegener ST, Riley LHI. Patient activation and adherence to physical therapy in persons undergoing spine surgery. Spine. 2008;33:E784–91.

Article  PubMed  PubMed Central  Google Scholar 

Skolasky RL, Riley LH, Maggard AM, Bedi S, Wegener ST. Functional recovery in lumbar spine surgery: a controlled trial of health behavior change counseling to improve outcomes. Contemp Clin Trials. 2013;36(1):207–17.

Article  PubMed  PubMed Central  Google Scholar 

Hendriks M, Rademakers J. Relationships between patient activation, disease-specific knowledge and health outcomes among people with diabetes; a survey study. BMC Health Serv Res. 2014;14(1):393.

Article  PubMed  PubMed Central  Google Scholar 

Gerber LM, Barrón Y, Mongoven J, McDonald M, Henriquez E, Andreopoulos E, et al. Activation among chronically ill older adults with Complex Medical needs: challenges to supporting effective self-management. J Ambul Care Manag. 2011;34(3):292–303.

Article  Google Scholar 

Kinney RL, Lemon SC, Person SD, Pagoto SL, Saczynski JS. The association between patient activation and medication adherence, hospitalization, and emergency room utilization in patients with chronic illnesses: a systematic review. Patient Educ Couns. 2015;98(5):545–52.

Article  PubMed  Google Scholar 

Remmers C, Hibbard J, Mosen DM, Wagenfield M, Hoye RE, Jones C. Is patient activation Associated with Future Health outcomes and Healthcare utilization among patients with diabetes? J Ambul Care Manag. 2009;32(4):320–7.

Article  Google Scholar 

Hibbard JH, Greene J, Overton V. Patients with Lower Activation Associated with higher costs; Delivery systems should know their patients’ ‘Scores’. Health Aff. 2013;32(2):216–22.

Article  Google Scholar 

Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4 Pt 1):1005–26.

Article  PubMed  PubMed Central  Google Scholar 

Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6 Pt 1):1918–30.

Article  PubMed  PubMed Central  Google Scholar 

Brenk-Franz K, Hibbard JH, Herrmann WJ, Freund T, Szecsenyi J, Djalali S, et al. Validation of the German version of the patient activation measure 13 (PAM13-D) in an International Multicentre Study of Primary Care patients. PLoS ONE. 2013;8(9):e74786.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zill JM, Dwinger S, Kriston L, Rohenkohl A, Härter M, Dirmaier J. Psychometric evaluation of the German version of the patient activation measure (PAM13). BMC Public Health. 2013;13:1027.

Article  PubMed  PubMed Central  Google Scholar 

Moljord IEO, Lara-Cabrera ML, Perestelo-Pérez L, Rivero-Santana A, Eriksen L, Linaker OM. Psychometric properties of the patient activation Measure-13 among out-patients waiting for mental health treatment: a validation study in Norway. Patient Educ Couns. 2015;98(11):1410–7.

Article  PubMed  Google Scholar 

Graffigna G, Barello S, Bonanomi A, Lozza E, Hibbard J. Measuring patient activation in Italy: translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I). BMC Med Inf Decis Mak. 2015;15:109.

Article  Google Scholar 

Ngooi BX, Packer TL, Kephart G, Warner G, Koh KW, Wong RC, et al. Validation of the patient activation measure (PAM-13) among adults with cardiac conditions in Singapore. Qual Life Res. 2017;26(4):1071–80.

Article  PubMed  Google Scholar 

Maindal HT, Sokolowski I, Vedsted P. Translation, adaptation and validation of the American short form patient activation measure (PAM13) in a Danish version. BMC Public Health. 2009;9:209.

Article  PubMed  PubMed Central  Google Scholar 

Zrubka Z, Vékás P, Németh P, Dobos Á, Hajdu O, Kovács L, et al. Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above. Eur J Health Econ. 2022;23(8):1341–55.

Article  PubMed  PubMed Central  Google Scholar 

Ahn YH, Yi CH, Ham OK, Kim BJ. Psychometric properties of the Korean Version of the patient activation measure 13 (PAM13-K) in patients with osteoarthritis. Eval Health Prof. 2015;38(2):255–64.

Article  PubMed  Google Scholar 

Magnezi R, Glasser S. Psychometric properties of the Hebrew translation of the patient activation measure (PAM-13). PLoS ONE. 2014;9(11):e113391.

Article  PubMed  PubMed Central  Google Scholar 

Rademakers J, Nijman J, van der Hoek L, Heijmans M, Rijken M. Measuring patient activation in the Netherlands: translation and validation of the American short form patient activation measure (PAM13). BMC Public Health. 2012;12:577.

Article  PubMed  PubMed Central  Google Scholar 

Bahrom NH, Ramli AS, Isa MR, Baharudin N, Badlishah-Sham SF, Mohamed-Yassin MS, et al. Validity and reliability of the patient activation Measure® (PAM®)-13 malay version among patients with metabolic syndrome in primary care. Malays Fam Physician. 2020;15(3):22–34.

CAS  PubMed  PubMed Central  Google Scholar 

Cunha CM, da Cunha DCPT, Manzato RO, Nepomuceno E, da Silva D, Dantas RAS. Validation of the Brazilian version of the patient activation measure 13. J Nurs Meas. (1):97–113.

Moreno-Chico C, González-de Paz L, Monforte-Royo C, Arrighi E, Navarro-Rubio MD. Gallart Fernández-Puebla A. Adaptation to European Spanish and psychometric properties of the patient activation measure 13 in patients with chronic diseases. Fam Pract. 2017;34(5):627–34.

Article  PubMed  Google Scholar 

Hellström A, Kassaye Tessma M, Flink M, Dahlgren A, Schildmeijer K, Ekstedt M. Validation of the patient activation measure in patients at discharge from hospitals and at distance from hospital care in Sweden. BMC Public Health. 2019;19(1):1701.

Article  PubMed  PubMed Central  Google Scholar 

Zakeri MA, Esmaeili Nadimi A, Bazmandegan G, Zakeri M, Dehghan M. Psychometric evaluation of chronic patients using the Persian Version of patient activation measure (PAM). Eval Health Prof. 2022:1632787221096904.

Kerari A, Almalki M, Bahari G, Alharbi MF. Validation of the Arabic Version of the patient activation measure (PAM-13) for application within the primary Healthcare Context in Saudi Arabia. Healthc (Basel). 2023;11(23).

Soejima T, Kitao M. Adaptation and measurement invariance of the 13-item version of patient activation measure across Japanese young adult cancer survivors during and after treatment: a cross-sectional observational study. PLoS ONE. 2023;18(9):e0291821.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fowles JB, Terry P, Xi M, Hibbard J, Bloom CT, Harvey L. Measuring self-management of patients’ and employees’ health: further validation of the patient activation measure (PAM) based on its relation to employee characteristics. Patient Educ Couns. 2009;77(1):116–22.

Article  PubMed  Google Scholar 

Lightfoot CJ, Wilkinson TJ, Memory KE, Palmer J, Smith AC. Reliability and validity of the patient activation measure in kidney disease: results of Rasch Analysis. Clin J Am Soc Nephrol. 2021;16(6):880–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Packer TL, Kephart G, Ghahari S, Audulv Å, Versnel J, Warner G. The patient activation measure: a validation study in a neurological population. Qual Life Res. 2015;24(7):1587–96.

Article  PubMed  Google Scholar 

Stepleman L, Rutter MC, Hibbard J, Johns L, Wright D, Hughes M. Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. Disabil Rehabil. 2010;32(19):1558–67.

Article  PubMed  Google Scholar 

Skolasky RL, Mackenzie EJ, Riley LH 3rd, Wegener ST. Psychometric properties of the patient activation measure among individuals presenting for elective lumbar spine surgery. Qual Life Res. 2009;18(10):1357–66.

Article  PubMed  PubMed Central  Google Scholar 

Zeng H, Jiang R, Zhou M, Wu L, Tian B, Zhang Y, et al. Measuring patient activation in Chinese patients with hypertension and/or diabetes: reliability and validity of the PAM13. J Int Med Res. 2019;47(12):5967–76.

Article  PubMed  PubMed Central